California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, AbbVie and 5AM Ventures, together with Johnson & Johnson Innovation, is proud to launch the CLSA Inspire QuickFire Challenge for Diverse Innovators, the first challenge in the CLSA Inspire series.
The California Life Sciences Association (CLSA) sponsored and introduced Assembly Bill (AB) 593, with Assemblymember Cottie Petrie-Norris (AD 74) which reinstates the Research and Development (R&D) Tax Credit and Net Operating Loss (NOL) deductions for life sciences companies in California for tax years 2021 and 2022.
Release of data analyzing the potential impact of international reference pricing (foreign price controls) on California’s biopharmaceutical innovation ecosystem, including investment into small company capital formation and the new drug development pipeline.
From holding Covid-19 vaccination events in San Francisco’s Tenderloin neighborhood to building programs that target longstanding inequities, the Bay Area biotech industry is stepping into high-profile social issues like never before.
Launch of CLSA/CLSI’s new Racial & Social Equity Initiative aims to address inequities faced by Black, Hispanic, Native American and Pacific Islander populations.
Senior level additions to leadership team demonstrate commitment to improved offerings and member experience.
Earlier this month, the Centers for Medicare and Medicaid Services (CMS) released the final “Medicare Coverage of Innovative Technology (MCIT) and Definition of ‘Reasonable and Necessary” rule (42 CFR Part 405).
This November, voters will have the opportunity to vote yes on Proposition 14 to authorize $5.5 billion in state general obligation bonds to continue the advancement of treatments and cures here in
On Tuesday, January 26, Governor Newsom revised the vaccine rollout plan to help streamline allocation and distribution.
CLSA issued a statement after the issuance of the Most Favored Nation (MFN) Interim Final Rule, and our subsequent legal action we have joined with our partners BIO and Biocom.